Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice

被引：0
|
作者：
Mansilla-Polo, Miguel [1 ,2 ]
Sahuquillo-Torralba, Antonio [1 ,2 ]
Pujol-Marco, Conrad [1 ,2 ]
Bargues-Navarro, Guillermo [1 ,2 ]
Botella-Estrada, Rafael [1 ,2 ,3 ]
机构：
[1] Hosp Univ & Politecn La Fe, Dept Dermatol, Valencia, Spain
[2] Inst Invest Sanitaria La Fe IIS La Fe, Dept Dermatol, Valencia, Spain
[3] Univ Valencia, Fac Med, Dept Dermatol, Valencia, Spain
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2024年 / 99卷 / 06期
关键词：
D O I：
10.1016/j.abd.2024.04.004
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：922 / 927
页数：6
相关论文
共 50 条
  • [1] Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment
    Mastorino, Luca
    Dapavo, Paolo
    Susca, Sara
    Cariti, Caterina
    Siliquini, Niccolo
    Verrone, Anna
    Stroppiana, Elena
    Ortoncelli, Michela
    Quaglino, Pietro
    Ribero, Simone
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (01): : 34 - 44
  • [2] Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [3] Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice
    Ruggiero, A.
    Fabbrocini, G.
    Cinelli, E.
    Garza, S. S. Ocampo
    Camela, E.
    Megna, M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (03) : 561 - 567
  • [4] A head-to-head comparison of risankizumab and ixekizumab for genital psoriasis: a real-life, 24-week, prospective study
    Sotiriou, E.
    Bakirtzi, K.
    Papadimitriou, I.
    Tsentemeidou, A.
    Eftychidou, P.
    Eleftheriadis, V.
    Lallas, A.
    Ioannides, D.
    Vakirlis, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (05) : E359 - E361
  • [5] Ixekizumab achieves more rapid reduction of circulating interleukin-19 compared to guselkumab in a psoriasis head-to-head study
    Konrad, R. J.
    Nickoloff, B. J.
    Higgs, R. E.
    Ferris, L. K.
    Reich, K.
    Elmaraghy, H.
    Gallo, G.
    Renda, L.
    Park, S.
    Krueger, J. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S68 - S68
  • [6] Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice
    Ruiz-Villaverde, Ricardo
    Ruiz-Carrascosa, Jose Carlos
    Galan-Gutierrez, Manuel
    Armario-Hita, Jose Carlos
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [7] Guselkumab: Short-term effectiveness and safety in real clinical practice
    Fernandez-Freire, Lourdes
    Galan-Gutierrez, Manuel
    Armario-Hita, Jose Carlos
    Perez-Gil, Amalia
    Ruiz-Villaverde, Ricardo
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [8] Comparative Effectiveness Without Head-to-Head TrialsA Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    James E. Signorovitch
    Eric Q. Wu
    Andrew P. Yu
    Charles M. Gerrits
    Evan Kantor
    Yanjun Bao
    Shiraz R. Gupta
    Parvez M. Mulani
    PharmacoEconomics, 2010, 28 : 935 - 945
  • [9] Comparative Effectiveness Without Head-to-Head Trials A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    Signorovitch, James E.
    Wu, Eric Q.
    Yu, Andrew P.
    Gerrits, Charles M.
    Kantor, Evan
    Bao, Yanjun
    Gupta, Shiraz R.
    Mulani, Parvez M.
    PHARMACOECONOMICS, 2010, 28 (10) : 935 - 945
  • [10] Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis
    Di Brizzi, Eugenia Veronica
    Buononato, Dario
    Benvenuto, Pierfrancesco
    Argenziano, Giuseppe
    De Pasquale, Rocco
    Fiorella, Carmen Silvia
    Giofre, Claudia
    Musumeci, Maria Letizia
    Palazzo, Giovanni
    Zichichi, Leonardo
    Balato, Anna
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (04):
12345